Candriam SCA’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-212,665
| Closed | -$5.79M | – | 700 |
|
|
2023
Q4 | $5.79M | Buy |
212,665
+83,000
| +64% | +$2.26M | 0.04% | 324 |
|
|
2023
Q3 | $3.12M | Hold |
129,665
| – | – | 0.02% | 374 |
|
|
2023
Q2 | $4.14M | Buy |
129,665
+50,000
| +63% | +$1.6M | 0.03% | 367 |
|
|
2023
Q1 | $2.25M | Hold |
79,665
| – | – | 0.02% | 554 |
|
|
2022
Q4 | $3.12M | Hold |
79,665
| – | – | 0.02% | 492 |
|
|
2022
Q3 | $3.8M | Hold |
79,665
| – | – | 0.03% | 444 |
|
|
2022
Q2 | $3.08M | Buy |
79,665
+2,518
| +3% | +$97.5K | 0.03% | 406 |
|
|
2022
Q1 | $4.42M | Hold |
77,147
| – | – | 0.03% | 373 |
|
|
2021
Q4 | $6.15M | Hold |
77,147
| – | – | 0.04% | 319 |
|
|
2021
Q3 | $6.71M | Hold |
77,147
| – | – | 0.05% | 335 |
|
|
2021
Q2 | $9.93M | Buy |
+77,147
| New | +$9.93M | 0.07% | 286 |
|